Del. Jury Says NanoString Owes $31M In 10x Patent Spat

November 17, 2023

WILMINGTON, DE – A federal jury in Wilmington, DE determined last Friday that Seattle-based NanoString Technologies Inc. willfully infringed several gene technology patents and awarded more than $31 million in damages to 10x Genomics Inc. The jury determined that NanoString deliberately infringed on seven patents owned by Prognosys Biosciences and which had been exclusively licensed to 10x Genomics with its GeoMx Digital Spatial Profiler product, all of which related to molecular profiling technology.

Impact Trial worked with teams from Tensegrity Law Group LLP and Richards, Layton & Finger, PA on behalf of their client, 10x Genomics, Inc.

Congratulations to our Impact members Bill Weir, Mindy Cho, Nova Hayes, Nelly Lin, Ouliana Nikolaeva-Hir, and Nancy Ramos on this victory! We are all very proud of the amount of time and effort that went into this case.

The case is 10x Genomics Inc. v. NanoString Technologies Inc., case number 1:21-cv-00653, in the U.S. District Court for the District of Delaware.

The patents-in-suit are U.S. Patent Nos. 10,472,669; 10,662,467; 10,961,566; 10,983,113; 10,996,219; 11,001,878; 11,008,607; and 11,293,917.